Jaw Joint Study: Fat Tissue Injection Shows Promise for TMJ Pain
Salvatore Sembronio, Alessandro Tel, Carlo Tremolada, Andrea Lazzarotto, Miriam Isola, Massimo Robiony · Journal of Oral and Maxillofacial Surgery · 2021
Randomized trial compares two treatments for jaw disorders
This Italian study tested whether injecting processed fat tissue into the jaw joint could work better than the current standard treatment. Researchers at the University of Udine enrolled 40 patients with temporomandibular joint (TMJ) disorders. All participants had tried conservative treatments like mouth guards, pain medications, and physical therapy without success.
The patients were randomly divided into two groups of 20. Both groups received arthrocentesis, a procedure that flushes out the jaw joint with saline solution. The difference was what came next: one group received a standard hyaluronic acid injection, while the other received micro-fragmented adipose tissue (specially processed fat from their own body) using Lipogems® technology.
Both treatments reduced pain and improved jaw movement
All 40 patients experienced meaningful improvements after treatment. Researchers tracked two main measures: pain levels and how wide patients could open their mouths. At checkups 10 days, one month, and six months after the procedure, both groups showed significant progress compared to their starting point.
This confirms that arthrocentesis itself is an effective treatment for TMJ internal derangement and osteoarthritis. The flushing action helps remove inflammatory substances from the joint and reduces friction that causes pain.
Fat tissue injection showed superior overall success rate
When researchers compared the two groups directly, patients who received the fat tissue injection had a statistically significant higher success rate. At the six-month follow-up:
Pain reduction nearly reached statistical significance (P = .0546)
Jaw opening improvement was statistically significant (P = .0327)
Overall treatment success favored the fat tissue group (P = .018)
These results suggest that the regenerative cells preserved in micro-fragmented fat tissue may provide additional healing benefits beyond what hyaluronic acid offers.
Minimally invasive procedure using your own tissue
The Lipogems® technique involves harvesting a small amount of fat tissue, typically from the abdomen, then processing it through a special device. This process breaks down the fat into tiny fragments while preserving the helpful cells within it. These include pericytes (helper cells that support blood vessel healing) and mesenchymal stem cells (regenerative cells that can support tissue repair).
Because the treatment uses your own tissue, there is no risk of rejection or allergic reaction. The entire procedure can be performed under local anesthesia in an outpatient setting.
First study to test this approach for jaw joints
While micro-fragmented adipose tissue has been studied extensively for knee and hip problems, this trial represents the first application specifically for TMJ disorders. The researchers note that the promising results encourage further investigation into this treatment option.
Researchers call for longer follow-up studies
The study authors acknowledge some limitations. The six-month follow-up period, while encouraging, may not capture the full picture of long-term outcomes. They recommend future studies with longer observation periods to confirm whether the improvements remain stable over time.
Additionally, the sample size of 40 patients, while sufficient for this preliminary trial, would benefit from larger studies to strengthen the findings.
For patients with TMJ internal derangement or osteoarthritis who have not responded to conservative treatments, this research suggests that arthrocentesis combined with micro-fragmented adipose tissue injection may offer meaningful advantages over standard hyaluronic acid treatment.
---
Source: Sembronio et al., Journal of Oral and Maxillofacial Surgery, 2021.
Original Publication
Temporomandibular Joint Arthrocentesis and Microfragmented Adipose Tissue Injection for the Treatment of Internal Derangement and Osteoarthritis: A Randomized Clinical Trial
Salvatore Sembronio, Alessandro Tel, Carlo Tremolada, Andrea Lazzarotto, Miriam Isola, Massimo Robiony · Journal of Oral and Maxillofacial Surgery · 2021
This randomized clinical trial compared temporomandibular joint (TMJ) arthrocentesis with microfragmented adipose tissue injection versus standard hyaluronic acid injection for treating internal derangement and osteoarthritis. Forty patients were enrolled: 20 received standard treatment (arthrocentesis plus hyaluronic acid injection) and 20 received experimental treatment (arthrocentesis plus microfragmented adipose tissue obtained through Lipogems technology). Primary outcomes measured were pain (visual analog scale) and function (maximum interincisal opening) assessed preoperatively and at 10 days, 1 month, and 6 months postoperatively. Both groups showed significant improvement in pain reduction and mouth opening compared to preoperative status (P = .001). At 6-month follow-up, the experimental group demonstrated near-significant pain reduction (P = .0546) and significant improvement in mouth opening (P = .0327) compared to preoperative values. Overall statistical analysis revealed the experimental group had significantly superior success rates compared to the control group (P = .018). These preliminary results indicate that microfragmented adipose tissue injection can significantly improve pain and functional outcomes compared to standard treatment. However, longer follow-up studies are needed to evaluate clinical stability of these improvements and further validate this regenerative approach for TMJ disorders.